HuGE Literature Finder
Records 1-3
Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients.
Cancer 2011 Jul 117 (14): 3156-62. Shulman Katerina, Cohen Ilana, Barnett-Griness Ofra, Kuten Abraham, Gruber Stephen B, Lejbkowicz Flavio, Rennert G |
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma.
Cancer 2008 May 112 (9): 1932-40. Liu Chun-Yu, Chen Po-Min, Chiou Tzeon-Jye, Liu Jin-Hwang, Lin Jen-Kou, Lin Tzu-Chen, Chen Wei-Shone, Jiang Jeng-Kae, Wang Huann-Sheng, Wang Wei-S |
Phase I pharmacokinetic, food effect, and pharmacogenetic study of oral irinotecan given as semisolid matrix capsules in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Feb 11 (4): 1504-11. Soepenberg Otto, Dumez Herlinde, Verweij Jaap, de Jong Floris A, de Jonge Maja J A, Thomas José, Eskens Ferry A L M, van Schaik Ron H N, Selleslach Johan, Ter Steeg Judith, Lefebvre Patricia, Assadourian Sylvie, Sanderink Ger-Jan, Sparreboom Alex, van Oosterom Allan |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: